Literature DB >> 23302633

Dilated cardiomyopathy: a disease of the myocardium.

Atsushi Sanbe1.   

Abstract

Cardiomyopathies are defined as cardiac diseases of the myocardium with associated cardiac dysfunction. They are cardiac diseases in which heart muscle disease and/or measurable deterioration of cardiac muscle function occurs due to various causes, such as genetic and sporadic mutations of muscle proteins, as well as external factors such as hypertension, ischemia, and inflammation. In 1995, the WHO/International Society and Federation of Cardiology (ISFC) classified primary cardiomyopathy caused by intrinsic factors into five groups according to the dominant pathophysiology: dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), restricted cardiomyopathy (RCM), arrhythmogenic right ventricular cardiomyopathy (ARVC), and unclassified cardiomyopathy. Among these cardiomyopathies, DCM is the most prevalent and the most common reason for cardiac transplantation in adults and children. Many recent findings indicate that genetic and sporadic mutations of a number of muscle proteins, such as myofibrillar, structural, and Ca(2+) regulating proteins, can cause DCM. In such cases, certain mutations often induce DCM with cardiac arrhythmia that is recognized as a potential trigger of sudden cardiac death. Thus, effective prognostic determination and appropriate cardiac care depend on accurate molecular and genetic diagnoses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23302633     DOI: 10.1248/bpb.b212023

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  13 in total

Review 1.  Use of stem cells in heart failure treatment: where we stand and where we are going.

Authors:  Luis A Sánchez; Carlos Enrique Guerrero-Beltrán; Andrea M Cordero-Reyes; Gerardo García-Rivas; Guillermo Torre-Amione
Journal:  Methodist Debakey Cardiovasc J       Date:  2013 Oct-Dec

Review 2.  Targeting the sarcomere to correct muscle function.

Authors:  Peter M Hwang; Brian D Sykes
Journal:  Nat Rev Drug Discov       Date:  2015-04-17       Impact factor: 84.694

3.  The prognostic value of right ventricular long axis strain in non-ischaemic dilated cardiomyopathies using standard cardiac magnetic resonance imaging.

Authors:  Nisha Arenja; Johannes H Riffel; Manuel Halder; Charly N Djiokou; Thomas Fritz; Florian Andre; Fabian Aus dem Siepen; Thomas Zelniker; Benjamin Meder; Elham Kayvanpour; Grigorios Korosoglou; Hugo A Katus; Sebastian J Buss
Journal:  Eur Radiol       Date:  2017-02-10       Impact factor: 5.315

Review 4.  Genetics of sudden cardiac death.

Authors:  Marwan M Refaat; Mostafa Hotait; Barry London
Journal:  Curr Cardiol Rep       Date:  2015-07       Impact factor: 2.931

5.  The evaluation of non-ischemic dilated cardiomyopathy with T1 mapping and ECV methods using 3T cardiac MRI.

Authors:  Cemile Ayşe Görmeli; Zeynep Maraş Özdemir; Ayşegül Sağır Kahraman; Jülide Yağmur; Ramazan Özdemir; Cemil Çolak
Journal:  Radiol Med       Date:  2016-10-27       Impact factor: 3.469

6.  Molecular Signature of Nitroso-Redox Balance in Idiopathic Dilated Cardiomyopathies.

Authors:  Sara Menazza; Angel Aponte; Junhui Sun; Marjan Gucek; Charles Steenbergen; Elizabeth Murphy
Journal:  J Am Heart Assoc       Date:  2015-09-22       Impact factor: 5.501

Review 7.  Genetic Variations Leading to Familial Dilated Cardiomyopathy.

Authors:  Kae Won Cho; Jongsung Lee; Youngjo Kim
Journal:  Mol Cells       Date:  2016-10-31       Impact factor: 5.034

8.  Effects of stem cell therapy on dilated cardiomyopathy.

Authors:  Rong Jiao; Yuan Liu; Wen-Jian Yang; Xiao-Yan Zhu; Jin Li; Qi-Zhu Tang
Journal:  Saudi Med J       Date:  2014-12       Impact factor: 1.484

Review 9.  Role of cardiac magnetic resonance in the evaluation of dilated cardiomyopathy: diagnostic contribution and prognostic significance.

Authors:  Marco Francone
Journal:  ISRN Radiol       Date:  2014-02-04

10.  Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced fibrogenesis in human cardiac fibroblasts.

Authors:  Meijuan Zou; Fang Wang; Rui Gao; Jingjing Wu; Yingwei Ou; Xuguan Chen; Tongshan Wang; Xin Zhou; Wei Zhu; Ping Li; Lian-Wen Qi; Ting Jiang; Weiwei Wang; Chunyu Li; Jun Chen; Qifang He; Yan Chen
Journal:  Sci Rep       Date:  2016-04-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.